Immunologically 'supercharged' monocytes as drivers of chronic fibrosis in idiopathic pulmonary fibrosis

E. Fraser (Oxford (Oxfordshire), United Kingdom), L. Denney (Oxford, United Kingdom), C. Vuppusetty (Oxford, United Kingdom), A. Antanaviciute (Oxford, United Kingdom), V. St.Noble (Oxford, United Kingdom), R. Benamore (Oxford, United Kingdom), R. Hoyles (Oxford, United Kingdom), L. Ho (Oxford (Oxfordshire), United Kingdom)

Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session: Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 819

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Fraser (Oxford (Oxfordshire), United Kingdom), L. Denney (Oxford, United Kingdom), C. Vuppusetty (Oxford, United Kingdom), A. Antanaviciute (Oxford, United Kingdom), V. St.Noble (Oxford, United Kingdom), R. Benamore (Oxford, United Kingdom), R. Hoyles (Oxford, United Kingdom), L. Ho (Oxford (Oxfordshire), United Kingdom). Immunologically 'supercharged' monocytes as drivers of chronic fibrosis in idiopathic pulmonary fibrosis. 819

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: